Two Rare Variants Explain Association with Acute Myocardial Infarction in an Extended Genomic Region Including the Apolipoprotein(A) Gene

被引:12
作者
Koch, Werner [1 ]
Mueller, Jakob C. [2 ]
Schrempf, Matthias [1 ]
Wolferstetter, Hannah [1 ]
Kirchhofer, Johannes [1 ]
Schoemig, Albert [1 ,3 ]
Kastrati, Adnan [1 ]
机构
[1] Deutsch Herzzentrum Munich, D-80636 Munich, Germany
[2] Max Planck Inst Ornithol, Dept Behav Ecol & Evolutionary Genet, Seewiesen, Germany
[3] Tech Univ Munich, Klinikum Rechts Isar, Med Klin, D-80290 Munich, Germany
关键词
Coronary artery disease; myocardial infarction; apolipoprotein(a); genetics; single nucleotide polymorphism; haplotype; FACTOR PATHWAY INHIBITOR; CORONARY-HEART-DISEASE; LIPOPROTEIN(A) LEVELS; CARDIOVASCULAR RISK; PLASMA LIPOPROTEIN(A); LP(A) LIPOPROTEIN; POLYMORPHISM; VISUALIZATION; PROBES; LOCUS;
D O I
10.1111/j.1469-1809.2012.00739.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Relatively low numbers of kringle 4 type 2 repeats in apolipoprotein(a) and specific haplotypes of the SLC22A3-LPAL2-LPA region on chromosome 6 are associated with an increased risk of coronary disease. We examined the possibility that rs3798220 and rs10455872, short variations located in LPA [the apolipoprotein(a) gene], and related to the number of kringle 4 type 2 repeats, may serve as markers for the association between haplotypes and acute myocardial infarction. Genotypes were determined with TaqMan assays in a sample of 2136 cases and 1211 controls. The minor alleles of rs3798220 and rs10455872 were associated with increased risks (rs3798220-C: adjusted OR 2.14, 95% CI, 1.37-3.33, P = 0.00080; rs10455872-G: adjusted OR 1.74, 95% CI 1.36-2.24, P < 0.00001). After adjustments were made for potential confounders, none of nine polymorphisms included in a haplotype analysis were singly related to disease. Two risk haplotypes were identified; one (CCTTGTGTG; OR 1.25, 95% CI 1.08-1.45, P = 0.0022) was correlated with rs3798220-C and the other (CCCTGGATC; OR 1.65, 95% CI 1.14-2.38, P = 0.0074) with rs10455872-G. Thus, the findings allowed for a more precise definition of risk-associated markers: specific nucleotides in LPA instead of standard haplotypes defined by noneffective variants from the extensive SLC22A3-LPAL2-LPA region.
引用
收藏
页码:47 / 55
页数:9
相关论文
共 46 条
[1]  
[Anonymous], 1985, World Health Organ Tech Rep Ser, V727, P1
[2]   Enigmatic Role of Lipoprotein(a) in Cardiovascular Disease [J].
Anuurad, Erdembileg ;
Enkhmaa, Byambaa ;
Berglund, Lars .
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2010, 3 (06) :327-332
[3]   Haploview: analysis and visualization of LD and haplotype maps [J].
Barrett, JC ;
Fry, B ;
Maller, J ;
Daly, MJ .
BIOINFORMATICS, 2005, 21 (02) :263-265
[4]   Lipoprotein(a) levels and risk of future coronary heart disease [J].
Bennet, Anna ;
Di Angelantonio, Ernanuele ;
Erqou, Sebhat ;
Eiriksdottir, Gudny ;
Sigurdsson, Gunnar ;
Woodward, Mark ;
Rumley, Ann ;
Lowe, Gordon D. O. ;
Danesh, John ;
Gudnason, Vilmundur .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (06) :598-608
[5]   Lipoprotein(a) An elusive cardiovascular risk factor [J].
Berglund, L ;
Ramakrishnan, R .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (12) :2219-2226
[6]   LOSS OF A SPLICE DONOR SITE AT A SKIPPED EXON IN A GENE HOMOLOGOUS TO APOLIPOPROTEIN(A) LEADS TO AN MESSENGER-RNA ENCODING A PROTEIN CONSISTING OF A SINGLE KRINGLE DOMAIN [J].
BYRNE, CD ;
SCHWARTZ, K ;
LAWN, RM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (01) :65-70
[7]   Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity [J].
Caplice, NM ;
Mueske, CS ;
Kleppe, LS ;
Simari, RD .
CIRCULATION, 1998, 98 (11) :1051-1057
[8]   Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis [J].
Caplice, NM ;
Panetta, C ;
Peterson, TE ;
Kleppe, LS ;
Mueske, CS ;
Kostner, GM ;
Broze, GJ ;
Simari, RD .
BLOOD, 2001, 98 (10) :2980-2987
[9]  
Chalmers J, 1999, CLIN EXP HYPERTENS, V21, P1009
[10]   Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy [J].
Chasman, Daniel I. ;
Shiffman, Dov ;
Zee, Robert Y. L. ;
Louie, Judy Z. ;
Luke, May M. ;
Rowland, Charles M. ;
Catanese, Joseph J. ;
Buring, Julie E. ;
Devlin, James J. ;
Ridker, Paul M. .
ATHEROSCLEROSIS, 2009, 203 (02) :371-376